ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

A Conversation with MSKCC’s José Baselga: We Need to Increase Our Reach

September 27, 2013

In Brief: Jefferson Cancer Center Received $10 Million donation, Renamed Kimmel Cancer Center

March 29, 1996

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979

NCI Cancer Prevention Fellowship Program

April 28, 2000